Literature DB >> 11514639

The relationship of akathisia with suicidality and depersonalization among patients with schizophrenia.

E Cem Atbaşoglu1, S K Schultz, N C Andreasen.   

Abstract

An association of suicidality and depersonalization with akathisia has been reported, but it is not clear whether these phenomena are specific to akathisia or are nonspecific manifestations of distress. The authors used the Barnes Akathisia Rating Scale, Brief Psychiatric Rating Scale, and Hamilton Rating Scale for Depression (Ham-D) to examine the relationships between suicidality, depersonalization, dysphoria, and akathisia in 68 patients with schizophrenia or schizophreniform disorder. Akathisia was associated with higher scores on the Ham-D ratings of suicidality, depersonalization, and agitation. In a logistic regression model, depressive mood and subjective awareness of akathisia appeared to be the only predictors of suicidality and depersonalization, respectively. These findings support the association between akathisia and both suicidality and depersonalization. However, these symptoms appear to be nonspecific responses to accompanying depressive mood and the subjective awareness of the akathisia syndrome, respectively.

Entities:  

Mesh:

Year:  2001        PMID: 11514639     DOI: 10.1176/jnp.13.3.336

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  15 in total

1.  Akathisia: a life-threatening side effect of a common medication.

Authors:  Hui M Cheng; Jae H Park; David Hernstadt
Journal:  BMJ Case Rep       Date:  2013-05-21

Review 2.  Managing suicide risk in patients with schizophrenia.

Authors:  John Kasckow; Kandi Felmet; Sidney Zisook
Journal:  CNS Drugs       Date:  2011-02       Impact factor: 5.749

Review 3.  Clozapine: in prevention of suicide in patients with schizophrenia or schizoaffective disorder.

Authors:  Antona Wagstaff; Caroline Perry
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

4.  Suicidal behavior in the older patient with schizophrenia.

Authors:  John Kasckow; Lori Montross; Laurie Prunty; Lauren Fox; Sidney Zisook
Journal:  Aging health       Date:  2011-06

5.  Incidence and risk factors of acute akathisia in 493 individuals with first episode non-affective psychosis: a 6-week randomised study of antipsychotic treatment.

Authors:  Maria Juncal-Ruiz; Mariluz Ramirez-Bonilla; Jorge Gomez-Arnau; Victor Ortiz-Garcia de la Foz; Paula Suarez-Pinilla; Obdulia Martinez-Garcia; Karl David Neergaard; Rafael Tabares-Seisdedos; Benedicto Crespo-Facorro
Journal:  Psychopharmacology (Berl)       Date:  2017-05-31       Impact factor: 4.530

6.  Suicidality and antidepressants in the elderly.

Authors:  David W Crumpacker
Journal:  Proc (Bayl Univ Med Cent)       Date:  2008-10

7.  Association of SOD2, GPX1, CAT, and TNF genetic polymorphisms with oxidative stress, neurochemistry, psychopathology, and extrapyramidal symptoms in schizophrenia.

Authors:  Marija Bošković; Tomaž Vovk; Marko Saje; Katja Goričar; Vita Dolžan; Blanka Kores Plesničar; Iztok Grabnar
Journal:  Neurochem Res       Date:  2012-12-02       Impact factor: 3.996

8.  Akathisia as an Extrapyramidal Side Effect of Fluoxetine.

Authors:  Ijeoma Ajufo; Tajudeen O Basiru
Journal:  Cureus       Date:  2021-06-21

9.  Persistent akathisia masquerading as agitated depression after use of ziprasidone in the treatment of bipolar depression.

Authors:  Thomas M Penders; Salina Agarwal; Rachel Rohaidy
Journal:  Neuropsychiatr Dis Treat       Date:  2013-04-04       Impact factor: 2.570

10.  Antidepressant-induced akathisia-related homicides associated with diminishing mutations in metabolizing genes of the CYP450 family.

Authors:  Yolande Lucire; Christopher Crotty
Journal:  Pharmgenomics Pers Med       Date:  2011-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.